Technology, Healthcare, Consumer Staples Nov 22, 2021 03:59 PM (GMT+8) · EqualOcean
Financial Associated Press, November 22 - Fu'an pharmaceutical announced that Tianheng pharmaceutical, a wholly-owned subsidiary, recently received a notice of approval for drug supplement application issued by the State Drug Administration, approving the addition of ambroxol hydrochloride injection 1ml: 7.5mg, which is mainly applicable to the expectorant treatment of acute exacerbation of chronic bronchitis, asthmatic bronchitis and bronchial asthma Preventive treatment of postoperative pulmonary complications, treatment of infant respiratory distress syndrome (IRDS) in preterm infants and newborns.